Merck & Co. stock is trading near its 52-week high after Guggenheim lifted its price target to 170.0

Ameritas Advisory Services LLC boosted its holdings in Merck & Co., Inc. (NYSE:MRK - Free Report) by 48.8% during the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 29,071 shares of the company

Leerink Partners increased their price target on shares of Merck & Co., Inc. from $127.00 to $161.00 and gave the stock an "outperform" rating in a research note on Wednesday.

NewEdge Advisors LLC raised its position in Merck & Co., Inc. (NYSE:MRK - Free Report) by 10.1% during the 2nd quarter, according to its most recent filing with the SEC. The institutional investor owned 455,515 shares of the company

Baird Financial Group Inc. lessened its holdings in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 8.5% during the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 1,064,683 shares of the company

At the close on September 8, 2026, Merck & Co. stock finished near USD 148 on the NYSE, down about 1

Allworth Financial LP decreased its holdings in Merck & Co., Inc. (NYSE:MRK - Free Report) by 20.7% in the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 208,546 shares of the company

Merck & Co. stock is trading near recent highs as Wells Fargo lifts its price target and investors f

VIRGINIA RETIREMENT SYSTEMS ET Al purchased a new stake in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 619,138 shares of the company

HighTower Advisors LLC grew its stake in Merck & Co., Inc. (NYSE:MRK - Free Report) by 1.2% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 3,679,920 shares of the company